Goldman Small Cap Research

Today we published a report and video on an innovative company that is developing a treatment for a life-threatening side effect of chemotherapy. Regen BioPharma Inc. (OTC:RGBP) is set to go from the preclinical stage to Phase I clinical trials for their stem cell-derived therapy to treat this condition, known as severe aplastic anemia (SAA). It is a $1 billion market and Regen has a deep pipeline and IP portfolio so we expect a great deal of performance from these undervalued and underfollowed shares. Companies typically get a big bump in value when they have an active Phase I trial.

See why one feature of this therapy could be a boon for the Company!
https://goldmansmallcapresearch.com/opportunity-research/regen-phase-i/
https://youtu.be/Sr8wmOXcfPQ?si=snhEoBxGO8G-VtKB

RGBP: Phase I Clinical Trial Candidate to Drive Valuation Higher – Goldman Small Cap Research RGBP: Phase I Clinical Trial Candidate to Drive Valuation Higher Posted on July 17, 2025July 17, 2025 by admin RGBP: Phase I Clinical Trial Candidate to Drive Valuation Higher Investment and Company Research Opportunity Research COMPANY REPORT July 17, 2025 REGEN BIOPHARMA, INC. (OTC – RGBP) Indus...

We published a report and video on a clean energy integrator poised to become a major player in upstate New York. Acadia Energy (OTC:AECX) is a great story and has exciting milestones ahead.

https://youtu.be/3GWGbfs17Qw?si=Amln5Uod9Jg_liBj

https://goldmansmallcapresearch.com/opportunity-research/aecx-clean-energy/

Clean Energy Innovator AECX Poised for Rare Growth Opportunity

PUR Biologics, the primary medtech subsidiary of HippoFi, Inc. (Ticker: ORHB) is hitting the ball out of the park. In just the past few months, the company had its biologics products used in spinal surgeries for bone regeneration approved for use in the entire VA health network---that's 171 medical centers and 1,113 outpatient sites serving millions of veterans. Plus, military bases. ORHB has also signed a deal to join forces w/an industry giant, introduced new products, and was awarded 2 new breakthrough patents. The stock appears to be a great entry point as the outcomes of these events should result in major price gains.

Undervalued, Underfollowed, High Growth MedTech Firm Offers Major Upside In what may be the best kept secret on Wall Street, emerging MedTech Firm HippoFi, Inc. (OTC:ORHB) is experiencing unprecedented sales growth. And that's just part of this innovator's story.

We have published new report out on The Healing Company (Ticker: HLCO), the next health and wellness unicorn. HLCO has a strong relationship with Deepak Chopra, who is the Chief Scientific Officer. The company also owns and operates Chopra Global which boasts a huge following, especially on social media. There are a series of acq deals ahead & a $150M M&A credit facility to draw down on which are poised to drive major sales growth. Plus, a NASDAQ uplisting in the cards. We currently have a $9 tgt price.

HLCO: A Burgeoning Health & Wellness Unicorn Leveraging a $150M M&A-targeted credit facility, and a core relationship with Deepak Chopra, integrated health firm The Healing Company, Inc. (OTCQB: HLCO) is poised to record exponential revenue grow

Wall Street's best kept secret!

We have just published a new report on HippoFi, Inc. (ORHB). It is an undervalued, underfollowed medtech provider that is experiencing unprecedented sales growth. This innovative company offers major upside, based on the values placed on its lower growth peers. As word gets out, and upcoming financials are released, we would not be surprised to see aggressive accumulation.

Undervalued, Underfollowed, High Growth MedTech Firm Offers Major Upside In what may be the best kept secret on Wall Street, emerging MedTech Firm HippoFi, Inc. (OTC:ORHB) is experiencing unprecedented sales growth. And that's just part of this innovator's story.

Good morning! We have an exciting new report our today on Camber Energy, Inc.: CEI on the NYSE. CEI may be the most diversified energy and power generation technology stock we've seen in some time. This undervalued co is set to close a merger with Viking Energy Group (VKIN) in 2H23 that serves as a catalyst to drive the combined companies' sales and CEI markedly higher. Check it out here:

Pending Merger Could Drive NYSE Player's Market Cap Higher The Camber Energy, Inc. (NYSE: CEI) pending merger with Viking Energy Group Inc. (OTC:VKIN) could drive CEI's market cap much higher as the combined company would emerge as one of the most diverse ene